DA-REPOCH Versus R-CHOP for the Treatment of Activated B-Cell Subtype Diffuse Large B-Cell Lymphoma: A Community Center Experience

Diffuse large B-cell lymphoma (DLBCL) represents around one quarter of non-Hodgkin lymphomas in both the United States and globally. The activated B-cell (ABC) subtype of DLBCL is associated with higher relapse rates and a worse prognosis when treated with standard regimens in comparison to other su...

Descripción completa

Detalles Bibliográficos
Autores principales: Knouse, Phillip, Nabrinsky, Edward, Sirota, Ronald L, Hakimian, David, Bitran, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704021/
https://www.ncbi.nlm.nih.gov/pubmed/33269174
http://dx.doi.org/10.7759/cureus.11714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704021/
https://www.ncbi.nlm.nih.gov/pubmed/33269174
http://dx.doi.org/10.7759/cureus.11714

Ejemplares similares